Lakefront Biotherapeutics | GLPG - Assets

Stock Price
23.40
Daily Change
-0.38 -1.60%
Monthly
-5.26%
Yearly
-5.11%
Q2 Forecast
22.89

Lakefront Biotherapeutics reported EUR3.37B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
argenx SE USD 8.68B 1.51B Dec/2025
AstraZeneca USD 114.02B 59M Mar/2026
Biogen USD 29.48B 43.6M Mar/2026
Genmab DKK 12.87B 5.85B Dec/2025
Gilead Sciences USD 56.28B 2.74B Mar/2026
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
GRIFOLS EUR 20.08B 366M Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Incyte USD 7.34B 381.14M Mar/2026
Merck EUR 51.53B 600M Dec/2025
Neurocrine Biosciences USD 4.91B 274.7M Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 128.02B 1.22B Mar/2026
UCB EUR 18.16B 971M Dec/2025
Vertex Pharmaceuticals USD 26.48B 841.4M Mar/2026